Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bering Capital is a venture capital firm based in San Francisco, California, dedicated to investing in biotech and medical technology companies. Founded to transform innovative ideas into successful ventures, the firm draws on the experience and insights gained from early pioneers in Silicon Valley and the venture capital landscape. Bering Capital aims to identify and support extraordinary entrepreneurs who are developing groundbreaking solutions in the healthcare sector.
Currently, Bering Capital operates primarily in North America, focusing on the biotech and healthcare sectors. The firm has built a notable portfolio that includes several companies recognized for their contributions to medical advancements. While specific metrics regarding fund size and team composition are not disclosed, Bering Capital's commitment to fostering innovation in healthcare is evident through its investment strategy and portfolio.
Bering Capital invests in cutting-edge biotech and medical technology companies, emphasizing the importance of identifying critical problems and acting decisively. The firm seeks extraordinary entrepreneurs who are developing innovative solutions within the healthcare sector. Bering Capital's investment strategy is centered around understanding the unique challenges faced by healthcare innovators and providing the necessary support to help them succeed.
The firm typically invests in early to growth-stage companies, although specific check size ranges are not provided. Bering Capital's geographic focus is primarily on North America, where it aims to partner with companies that are at the forefront of medical technology advancements. The firm values a strong alignment with founders who demonstrate a clear vision and a commitment to transforming healthcare through their innovations.
Bering Capital's portfolio includes several notable companies that are making significant strides in the biotech and healthcare sectors:
In addition to its current investments, Bering Capital has a history of successful exits, including:
Evgeny Zaytsev, MD, PhD - Managing Partner. Evgeny has extensive experience in the biotech sector and has led numerous successful investments in healthcare innovation.
Philip Sawyer - Managing Partner. Philip brings a wealth of knowledge in venture capital and has a strong track record of supporting early-stage companies.
Christopher Alafi, DPhil - Advisor. Christopher has a background in life sciences and provides strategic insights to portfolio companies.
George Painter, PhD - Advisor. George is an expert in drug development and offers guidance on scientific and regulatory matters.
Stephen A. Sherwin, MD - Advisor. Stephen has significant experience in clinical development and helps portfolio companies navigate the complexities of bringing products to market.
Gregory B. Brown, MD - Advisor. Gregory specializes in healthcare investments and provides valuable insights into market trends and opportunities.
To pitch Bering Capital, founders should prepare a comprehensive deck that includes an overview of their business, market analysis, and financial projections. The preferred channel for submissions is through a warm introduction, although cold outreach is also accepted. Founders can expect a response within a few weeks, depending on the volume of inquiries.
In recent months, Bering Capital has continued to expand its portfolio in the biotech sector, focusing on companies that are developing innovative healthcare solutions. The firm has made several new investments, although specific details regarding these transactions have not been disclosed.
Notable exits from Bering Capital's portfolio include Atea Pharmaceuticals and Coherus BioSciences, both of which successfully went public on NASDAQ. These exits highlight the firm's ability to identify and support companies that achieve significant milestones in the healthcare industry.
What are Bering Capital's investment criteria?
Bering Capital focuses on investing in biotech and medical technology companies that address critical healthcare challenges. The firm looks for extraordinary entrepreneurs with innovative solutions and a strong vision for their companies.
How can I apply or pitch to Bering Capital?
Founders interested in pitching to Bering Capital should prepare a detailed presentation that outlines their business model, market opportunity, and the unique value proposition of their product or service. A warm introduction is preferred, but cold outreach is also accepted.
What makes Bering Capital different from other venture firms?
Bering Capital distinguishes itself through its deep focus on the biotech and medical technology sectors, leveraging insights from Silicon Valley pioneers. The firm emphasizes the importance of extraordinary entrepreneurs and innovative healthcare solutions.
What is Bering Capital's geographic scope?
The firm primarily invests in North America, targeting companies that are developing groundbreaking solutions in the biotech and healthcare industries.
What is Bering Capital's post-investment involvement?
Bering Capital actively supports its portfolio companies through strategic guidance, operational support, and access to its extensive network within the healthcare sector. The firm aims to foster growth and innovation in its investments.
What is the typical check size for investments?
While specific check sizes are not disclosed, Bering Capital typically invests in early to growth-stage companies, aligning its financial support with the needs of its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.